Trial Confirms ‘Life-Changing’ Impact of Gene Therapy for Hemophilia B
THURSDAY, Sept. 25, 2024 (HealthDay News) — A new gene therapy approved earlier this year can serve as a sustainable single-dose treatment for people with hemophilia B, newly published clinical trial data shows. People with hemophilia B saw their bleeding episodes drop by an average 71% following a single infusionContinue Reading